LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 2 | M20 | 72 | hr | 513 | 697 | 10401 | 0.0670 | 0.0186 |
MCF 10A | Erlotinib | 3.33 | uM | LJP5 | 3 | M20 | 72 | hr | 513 | 688 | 10401 | 0.0661 | 0.0177 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 1 | H08 | 72 | hr | 513 | 1140 | 10401 | 0.1096 | 0.0634 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 2 | H08 | 72 | hr | 513 | 1156 | 10401 | 0.1111 | 0.0650 |
MCF 10A | Foretinib | 3.33 | uM | LJP5 | 3 | H08 | 72 | hr | 513 | 1146 | 10401 | 0.1102 | 0.0640 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 1 | C14 | 72 | hr | 513 | 4581 | 10401 | 0.4404 | 0.4114 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 2 | C14 | 72 | hr | 513 | 5335 | 10401 | 0.5129 | 0.4876 |
MCF 10A | R406 | 3.33 | uM | LJP6 | 3 | C14 | 72 | hr | 513 | 5986 | 10401 | 0.5755 | 0.5535 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 1 | D20 | 72 | hr | 513 | 948 | 10401 | 0.0911 | 0.0440 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 2 | D20 | 72 | hr | 513 | 1200 | 10401 | 0.1154 | 0.0694 |
MCF 10A | Pictilisib | 3.33 | uM | LJP6 | 3 | D20 | 72 | hr | 513 | 1165 | 10401 | 0.1120 | 0.0659 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 1 | N08 | 72 | hr | 513 | 919 | 10401 | 0.0884 | 0.0410 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 2 | N08 | 72 | hr | 513 | 760 | 10401 | 0.0731 | 0.0249 |
MCF 10A | Gefitinib | 3.33 | uM | LJP6 | 3 | N08 | 72 | hr | 513 | 680 | 10401 | 0.0654 | 0.0169 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP5 | 1 | O02 | 72 | hr | 513 | 400 | 10401 | 0.0385 | -0.0115 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP5 | 2 | O02 | 72 | hr | 513 | 329 | 10401 | 0.0316 | -0.0186 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP5 | 3 | O02 | 72 | hr | 513 | 439 | 10401 | 0.0422 | -0.0075 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP6 | 1 | O02 | 72 | hr | 513 | 366 | 10401 | 0.0352 | -0.0149 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP6 | 2 | O02 | 72 | hr | 513 | 375 | 10401 | 0.0361 | -0.0140 |
MCF 10A | Geldanamycin | 3.33 | uM | LJP6 | 3 | O02 | 72 | hr | 513 | 438 | 10401 | 0.0421 | -0.0076 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 513 | 275 | 10401 | 0.0264 | -0.0241 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 513 | 403 | 10401 | 0.0387 | -0.0112 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 513 | 368 | 10401 | 0.0354 | -0.0147 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 513 | 417 | 10401 | 0.0401 | -0.0097 |
MCF 10A | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 513 | 448 | 10401 | 0.0431 | -0.0066 |